GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Price-to-Owner-Earnings

3SBio, (FRA:YFK) Price-to-Owner-Earnings : 41.83 (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is 3SBio, Price-to-Owner-Earnings?

As of today (2024-04-29), 3SBio,'s share price is €12.55. 3SBio,'s Owner Earnings per Share (TTM) ended in Dec. 2016 was €0.30. It's Price-to-Owner-Earnings for today is 41.83.


The historical rank and industry rank for 3SBio,'s Price-to-Owner-Earnings or its related term are showing as below:

FRA:YFK' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 22.45   Med: 30.76   Max: 41.96
Current: 41.96

During the past 13 years, the highest Price-to-Owner-Earnings of 3SBio, was 41.96. The lowest was 22.45. And the median was 30.76.


FRA:YFK's Price-to-Owner-Earnings is not ranked
in the Biotechnology industry.
Industry Median: 32.12 vs FRA:YFK: 41.96

As of today (2024-04-29), 3SBio,'s share price is €12.55. 3SBio,'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was €0.00. Therefore, 3SBio,'s PE Ratio for today is N/A.

As of today (2024-04-29), 3SBio,'s share price is €12.55. 3SBio,'s EPS without NRI for the trailing twelve months (TTM) ended in was €0.00. Therefore, 3SBio,'s PE Ratio without NRI for today is N/A.

During the past 13 years, 3SBio,'s highest PE Ratio without NRI was 43.58. The lowest was 23.32. And the median was 31.22.


3SBio, Price-to-Owner-Earnings Historical Data

The historical data trend for 3SBio,'s Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Price-to-Owner-Earnings Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of 3SBio,'s Price-to-Owner-Earnings

For the Biotechnology subindustry, 3SBio,'s Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Price-to-Owner-Earnings falls into.



3SBio, Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

3SBio,'s Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12.55/0.30
=41.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio,  (FRA:YFK) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


3SBio, Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines